Literature DB >> 11334969

Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats.

S Ebner1, S Neyer, S Hofer, W Nussbaumer, N Romani, C Heufler.   

Abstract

Many blood banks now use whole blood inline filtration to produce leukocyte-depleted blood products. As a result, a common source of large numbers of human dendritic cells (DC) for research purposes, namely standard buffy coats, has been lost. Therefore, we have adapted our conventional method for growing DC from CD14(+) precursors in order to make use of these filter units. A dextran solution containing human serum albumin was used to flush back the filters. After pelleting, mononuclear cells were obtained by standard density gradient centrifugation (Lymphoprep). To eliminate T cells, we used rosetting with sheep red blood cells. In addition to the classical PBMC, the cell population obtained after Lymphoprep centrifugation was found to contain high numbers of CD14(+) granulocytes which could be depleted by separation on an additional Percoll gradient. At this stage, FACS analysis revealed a cell population that resembled the CD14(+) monocyte-enriched population, obtained from traditional buffy coat preparations after Lymphoprep centrifugation and T cell elimination. Culture of the cells and the induction of maturation was identical to the previously described procedures, except that the culture time was reduced from 7 to 5 days and the maturation time from 3 to 2 days. Analyses of the major molecules indicative of DC maturation (CD83, CD86, CD208/DC-LAMP) and functional analyses of the T cell-stimulatory capacity of the DC population (using the MLR assay with normal peripheral T cells and naive T cells) revealed no major differences from buffy coat-derived DC preparations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334969     DOI: 10.1016/s0022-1759(01)00337-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.

Authors:  Narutoshi Hibino; Ani Nalbandian; Lesley Devine; Rajendra Sawh Martinez; Edward McGillicuddy; Tai Yi; Safa Karandish; Girolamo A Ortolano; Toshiharu Shin'oka; Edward Snyder; Christopher K Breuer
Journal:  Tissue Eng Part C Methods       Date:  2011-07-01       Impact factor: 3.056

2.  Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2.

Authors:  Oliver Grauer; Peter Pöschl; Annette Lohmeier; Gosse J Adema; Ulrich Bogdahn
Journal:  J Neurooncol       Date:  2006-11-15       Impact factor: 4.130

3.  TCR-mediated functions are enhanced in activated peripheral blood T cells isolated from leucocyte reduction systems.

Authors:  Mikaela M Tremblay; Jon C D Houtman
Journal:  J Immunol Methods       Date:  2014-11-25       Impact factor: 2.303

4.  Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells.

Authors:  M Colic; Z Stojic-Vukanic; B Pavlovic; D Jandric; I Stefanoska
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

5.  Peptides from allergenic lipocalins bind to formyl peptide receptor 3 in human dendritic cells to mediate TH2 immunity.

Authors:  Dominik Klaver; Beate Posch; Anita Geisler; Martin Hermann; Norbert Reider; Christine Heufler
Journal:  J Allergy Clin Immunol       Date:  2019-07-19       Impact factor: 10.793

6.  In human monocyte derived dendritic cells SOCS1 interacting with CYTIP induces the degradation of CYTIP by the proteasome.

Authors:  Daniela Grabher; Susanne Hofer; Daniela Ortner; Christine Heufler
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

7.  Allergenic Can f 1 and its human homologue Lcn-1 direct dendritic cells to induce divergent immune responses.

Authors:  Beate Posch; Christian Irsara; Fabian S Gamper; Martin Herrmann; Daniel Bindreither; Dietmar Fuchs; Norbert Reider; Bernhard Redl; Christine Heufler
Journal:  J Cell Mol Med       Date:  2015-07-27       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.